Citrome L - Search Results

1

Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070).

Suzuki K, Castelli M, Komaroff M, Starling B, Terahara T, Citrome L. Suzuki K, et al. Among authors: citrome l. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):286-294. doi: 10.1097/JCP.0000000000001383. J Clin Psychopharmacol. 2021. PMID: 33734167 Free PMC article. Clinical Trial.

2

High-dose treatment with haloperidol: the effect of dose reduction.

Volavka J, Cooper TB, Czobor P, Lindenmayer JP, Citrome LL, Mohr P, Bark N. Volavka J, et al. Among authors: citrome ll. J Clin Psychopharmacol. 2000 Apr;20(2):252-6. doi: 10.1097/00004714-200004000-00020. J Clin Psychopharmacol. 2000. PMID: 10770466 Clinical Trial.

3

Pharmacokinetics of aripiprazole and concomitant carbamazepine.

Citrome L, Macher JP, Salazar DE, Mallikaarjun S, Boulton DW. Citrome L, et al. J Clin Psychopharmacol. 2007 Jun;27(3):279-83. doi: 10.1097/jcp.0b013e318056f309. J Clin Psychopharmacol. 2007. PMID: 17502775 Clinical Trial.

4

Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.

Citrome L, Stauffer VL, Chen L, Kinon BJ, Kurtz DL, Jacobson JG, Bergstrom RF. Citrome L, et al. J Clin Psychopharmacol. 2009 Jun;29(3):278-83. doi: 10.1097/JCP.0b013e3181a289cb. J Clin Psychopharmacol. 2009. PMID: 19440083

5

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.

Citrome L. Citrome L. Int J Clin Pract. 2009 Dec;63(12):1762-84. doi: 10.1111/j.1742-1241.2009.02228.x. Epub 2009 Oct 14. Int J Clin Pract. 2009. PMID: 19840150 Review.

6

A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder.

Lindenmayer JP, Citrome L, Khan A, Kaushik S, Kaushik S. Lindenmayer JP, et al. Among authors: citrome l. J Clin Psychopharmacol. 2011 Apr;31(2):160-8. doi: 10.1097/JCP.0b013e31820f4fe0. J Clin Psychopharmacol. 2011. PMID: 21346616 Clinical Trial.

7

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.

Citrome L, Meng X, Hochfeld M, Stahl SM. Citrome L, et al. Hum Psychopharmacol. 2012 Jan;27(1):24-32. doi: 10.1002/hup.1254. Epub 2011 Dec 7. Hum Psychopharmacol. 2012. PMID: 22161738 Clinical Trial.

8

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.

Citrome L, Cucchiaro J, Sarma K, Phillips D, Silva R, Tsuchiya S, Loebel A. Citrome L, et al. Int Clin Psychopharmacol. 2012 May;27(3):165-76. doi: 10.1097/YIC.0b013e32835281ef. Int Clin Psychopharmacol. 2012. PMID: 22395527 Clinical Trial.

9

High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.

Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA. Goff DC, et al. Among authors: citrome l. J Clin Psychopharmacol. 2013 Aug;33(4):485-90. doi: 10.1097/JCP.0b013e3182977308. J Clin Psychopharmacol. 2013. PMID: 23775057 Clinical Trial.

10

Asenapine review, part II: clinical efficacy, safety and tolerability.

Citrome L. Citrome L. Expert Opin Drug Saf. 2014 Jun;13(6):803-30. doi: 10.1517/14740338.2014.908183. Epub 2014 May 3. Expert Opin Drug Saf. 2014. PMID: 24793161 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

513 results

Search Page